Gene · 1859
Papers3,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmaco-behavioral profiling identifies suppressors of autism gene-associated phenotypes in zebrafish. | Proc Natl Acad Sci U S A | 2026 | 41838920 | PubTator, text mining | PubMed |
| Harmine and its derivatives: A promising multi-target therapeutic avenue for Alzheimer's disease. | Neuroscience | 2026 | 41812815 | PubTator, text mining | PubMed |
| Ocular manifestations in DYRK1A mutation: a five-case series from South Korea. | Ophthalmic Genet | 2026 | 41804029 | PubTator, text mining | PubMed |
| From genes to networks: neurobiological bases of neurodiversity across common developmental disorders. | Front Neurosci | 2026 | 41799890 | PubTator, text mining | PubMed |
| Editorial: Advances in DYRK1A syndrome: underlying mechanisms, disease models, and novel therapeutic approaches. | Front Neurosci | 2026 | 41799883 | PubTator, text mining | PubMed |
| Mechanisms inducing differentiation of adult islet progenitor-like cells into functional islet-like organoids. | Front Transplant | 2026 | 41798991 | PubTator, text mining | PubMed |
| Correction: DYRK1A roles in human neural progenitors. | Front Neurosci | 2026 | 41777738 | PubTator, text mining | PubMed |
| Targeting NAT10 alleviates colonic senescence and elderly-onset colitis by disrupting N4-acetylation of DYRK1A. | Nat Commun | 2026 | 41764178 | PubTator, text mining | PubMed |
| Molecular evolution of animal aging. | EMBO J | 2026 | 41760805 | PubTator, text mining | PubMed |
| Defining the Active Conformation of Typical Protein Kinase Domains from Substrate-Bound PDB Structures Enables Active-State AlphaFold2 Models for All 437 Human Catalytic Protein Kinases. | bioRxiv | 2026 | 41757035 | PubTator, text mining | PubMed |
| Molecular pattern of acquiring upper respiratory infection. | Front Med (Lausanne) | 2026 | 41728619 | PubTator, text mining | PubMed |
| First 2-year experience of nationwide newborn screening for severe forms of T and B cell immunodeficiency: 2.3 million newborns analyzed using TREC and KREC in Russia. | Front Immunol | 2026 | 41727503 | PubTator, text mining | PubMed |
| Late-Onset Depression in an Aging World: A Multidimensional Perspective on Risks, Mechanisms, and Treatment. | Geriatrics (Basel) | 2026 | 41718361 | PubTator, text mining | PubMed |
| Biomarkers in Alzheimer's disease clinical trials: 2025. | Alzheimers Dement (N Y) | 2026 | 41716297 | PubTator, text mining | PubMed |
| Single-cell profiling reveals FAM117A as a key regulator linking macrophage-epithelial crosstalk with the progression of lung adenocarcinoma. | Exp Hematol Oncol | 2026 | 41692823 | PubTator, text mining | PubMed |
| Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 iPSC-derived neural cells. | bioRxiv | 2026 | 41676546 | PubTator, text mining | PubMed |
| Targeting dual specificity tyrosine-phosphorylation-regulated kinase 1A mitigates tauopathy and enhances recovery after repetitive head injury. | Neurotherapeutics | 2026 | 41651695 | PubTator, text mining | PubMed |
| Decoding SR protein regulation: kinases, phosphatases, and therapeutic targeting strategies. | Cell Oncol (Dordr) | 2026 | 41636961 | PubTator, text mining | PubMed |
| Generation of a human induced pluripotent stem cell line (FDIBSi002-A) derived from a patient with DYRK1A syndrome carrying a heterozygous DYRK1A mutation (c.1042G>A). | Stem Cell Res | 2026 | 41621215 | PubTator, text mining | PubMed |
| DYRK1A Expression and Thyroid Dysfunction in Subjects With Down Syndrome. | Clin Endocrinol (Oxf) | 2026 | 41611636 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1859/papers?page=4